/Cencora%20Inc_%20chart%20on%20phone-by%20T_Schneider%20via%20Shutterstock.jpg)
With a market capitalization of $61.8 billion, Pennsylvania-based Cencora, Inc. (COR) is a leading global pharmaceutical services and drug distribution company, formerly known as AmerisourceBergen. It plays a critical role in the healthcare supply chain, acting as an intermediary between drug manufacturers and healthcare providers.
The company is expected to release its Q2 2026 earnings results on Tuesday, May 6, before the market opens. Ahead of this event, analysts anticipate Cencora to generate earnings of $4.81 per share, representing an increase of 8.8% from $4.42 per share reported in the same quarter last year. The company has surpassed the Street’s bottom-line estimates in each of the past four quarters.